All ArticlesCompany news
Company news

Carrot publishes industry-leading single embryo transfer (SET) rate with validated methodology

Carrot publishes industry-leading single embryo transfer (SET) rate with validated methodology

Carrot and Milliman logos
Jan 18, 2023
Share on LinkedIn

Carrot’s fertility healthcare and family-forming platform is proven to help members have healthier pregnancies and babies. Today, we’re proud to publish the results of an internal study demonstrating the highest reported single embryo transfer (SET) rate of fertility benefits vendors as well as an IVF pregnancy rate greatly exceeding national averages.

We achieve our industry-leading single embryo transfer (SET) rate through our flexible plan design, which meaningfully improves medical outcomes, including healthy pregnancies and successful future live births, without also contributing to the overuse of expensive and sometimes unnecessary interventions. Carrot enables access to personalized, evidence-based care based on member needs rather than prescribing a predefined course of treatments in a one-size-fits-all approach. Members receive medical care within Carrot’s vetted provider network and seek additional guidance and around-the-clock support through Carrot’s team of care navigators and fertility experts. Carrot’s coverage is comprehensive, age inclusive, and provides benefits across a wide variety of member journeys, including fertility, pregnancy, adoption, gestational surrogacy services, menopause, low testosterone, and more.

Carrot engaged Milliman, Inc., an independent global leader in actuarial services, to evaluate the methodology Carrot used to evaluate and compare the various fertility treatment measures of its members to national benchmarks. Milliman found the general methodology used to compare measures between Carrot data to these benchmarks to be appropriate and reasonable. Read the full report.

Dr. Asima Ahmad in a white coat
Dr. Asima Ahmad, MD, MPH, Carrot's Co-founder and Chief Medical Officer

“For years, Carrot’s personalized care navigation has met members where they are and optimized for healthy outcomes and cost-effectiveness,” said Dr. Asima Ahmad, Co-founder and Chief Medical Officer, Carrot Fertility. “This study further validates our team's work to provide education around medically-appropriate care based on the latest clinical guidelines. We’re proud to offer a benefit that makes a meaningful impact on our members’ lives.”

SET is the single most predictive indicator of a singleton IVF pregnancy and subsequent successful singleton live birth.
IVF pregnancy rates demonstrate the success rates of embryo transfers.
PGT-A allows providers to assess the genetic status of an embryo prior to transfer and can impact IVF pregnancy rates in certain populations; Carrot's utilization of PGT-A is aligned with the demographics of these recommended populations.

Carrot's SET program

Some of the most commonly used measures to assess the success of fertility treatments and likelihood of a healthy singleton pregnancy and live birth include SET rate and IVF pregnancy rate. SET is the single most predictive indicator of a singleton IVF pregnancy and subsequent successful live birth. It is an important clinical protocol used to avoid multiple gestation pregnancies, which are associated with higher medical costs and poorer health outcomes for mothers and infants. Preterm birth, low birth weight, neurological impairments, and death are more common outcomes of multiple gestation pregnancies compared to singleton pregnancies.

Along with provider partnerships that enable access to valuable data, Carrot members receive education and navigation to medically appropriate care based on the most up-to-date clinical best practices, delivering proven ROI to employers.

Industry-leading outcomes: Better experiences, lower costs

Research shows that about 10% of all babies are born preterm every year, which can be incredibly taxing emotionally and financially. By focusing on clinical best practices and obtaining industry-leading SET rates — the single most predictive indicator of a singleton IVF pregnancy and subsequent successful singleton live birth — Carrot leads to better outcomes, better member experiences, and, ultimately, lower costs.

Any general advice posted on our blog, website, app or social media platform is for informational purposes only and is not intended to replace or substitute for any medical advice, diagnosis, or treatment. Carrot Fertility makes no representations or warranties and expressly disclaims any and all liability concerning any treatment, action by, or effect on any person following the general information offered or provided within or through the blog, website, app or social media platform. As Carrot is distinct from any third party providers with whom we partner to provide applications, products, and services to members, we are not responsible for the quality, integrity, safety, accuracy, availability, reliability, or legality of such third party applications, products, and services. Further, Carrot is not responsible or liable, directly or indirectly, for any damage, harm, injury, or loss of any kind caused or alleged to be caused by or in connection with the use of or reliance upon any content, material, or services available through any third party providers.
Read more
Company news
Carrot recognized as a certified age-friendly employer
Carrot is a Certified Age Friendly Employer (CAFE), presented by the Age-Friendly Institute.
Fertility care
What to know about PCOS: Advice from our partners in Asia
Polycystic ovary syndrome (PCOS) impacts people around the world. We spoke to some of our partners in Asia to learn more about the condition.
Why health plans should get ahead of mandated fertility coverage
19 states in the U.S. have mandates requiring large group insurers to provide fertility coverage. Learn why this trend isn't slowing down.
See how Carrot can transform your company
Find out how our customizable fertility solutions can help your plan, your groups, and your members.
Get Started